Diagnostics & biomarkers

Cardiac Amyloidosis Has a Diagnostic Grey Zone. A New PET Tracer Could Help Close It

HER2-Mutant Lung Cancer Just Moved Into First Line

A New Global Heart Attack Definition Targets a Diagnostic Blind Spot in Women

Breast Cancer Just Proved Why Biomarker Selection Matters

Brain Cancer Finally Gets the PET Scan It Has Been Missing

Heart calcium scans add little for most patients. Their real value may be in the uncertain middle

Alzheimer’s PET Is Becoming Data Infrastructure

The mRNA Cancer Vaccine Story Just Got Less Comfortable

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
